Note: Ingredients listed on restricted chemical lists
EC/CAS
220-239-6/2682-20-4
Name of the chemical
2-Methyl-2H-isothiazol-3-one
Concentration
>0.0015-<0.01% 0.0015%
EC/CAS
223-296-5/3811-73-2
Name of the chemical
Pyridine-2-thiol 1-oxide, sodium salt
Concentration
<0.01%
EC/CAS
220-120-9/2634-33-5
Name of the chemical
1,2-Benzisothiazol-3(2H)-one
Concentration
>0.0015-<0.01% 0.036% <5%
General Information
Version
9.00 (replaces version 8.00
Revision date
2024-08-05
Product name
SONAX Wash+Shine
1.2.2. Uses advised against
There is currently no information available on this
Emergency telephone
(+44) 01929 551557, +49 (0) 89 19240, 0344 892 0111
Icons in SDS
Company Information
company name
SONAX GmbH
e-mail address of the competent person responsible for the Safety Data Sheet
erp@sonax.de, info@aaoil.co.uk
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H317
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 Classification of the substance or mixture
Hazard pictograms
GHS07
Hazardous Ingredients
2-methylisothiazol-3(2H)-one 1,2-benzisothiazol-3(2H)-one
Hazard statements
H317 May cause an allergic skin reaction.
Precautionary statements
P101 If medical advice is needed, have product container or label at hand. P102 Keep out of reach of children. P280 Wear protective gloves. P302+P352 IF ON SKIN: Wash with plenty of water. (Contd. on page 2) GB (Contd. of page 1) P333+P313 If skin irritation or rash occurs: Get medical advice/attention. P501 Dispose of contents/container in accordance with local/regional/national/international regulations.
PBT Substances
According to information provided in the supply chain, the mix contains less than 0.1% of any substances classified as PBT
vPvB Substances
According to information provided in the supply chain, the mix contains less than 0.1% of any substances classified as vPvB. Determination of endocrine-disrupting properties The substance/mixture does not contain components considered to have endocrine disrupting properties according to UK REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher. *
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008 Skin Sens. 1A H317 May cause an allergic skin reaction.
